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Background: Delayed re-endothelialization after drug-eluting stent (DES) implantation may predispose to stent thrombosis. Leukocyte telomere 
length (LTL) reflects the proliferative potential of endothelial cells. We hypothesized that LTL predicts the degree of stent strut coverage after DES 
implantation.
Methods: Twenty subjects with prior DES implantation had follow-up optical coherence tomography (OCT) imaging. Strut-level and cross-sectional 
measurements were made at a core laboratory by investigators blinded to clinical information. Blood samples were obtained at the time of OCT 
imaging. Relative LTL was measured by quantitative polymerase chain reaction (PCR).
Results: Sixteen (80%) patients had a sirolimus-eluting stent placed, and 4 (20%) had a paclitaxel-eluting stent placed. Mean stent length was 
25±7.7 mm; mean stent diameter was 3.0±0.4 mm. Time from stent implantation to OCT was 6.0±0.2 months. At follow-up OCT imaging, the percent 
of uncovered stent struts was 11.7±9.4%, the percent cross section with uncovered struts was 15.2 ± 15.6%, and the mean neointimal thickness 
was 127±88 μM. LTL was inversely correlated with the percent cross-section with uncovered struts (R2=0.22, p=0.04) and stent strut coverage 
(R2=0.31, p=0.01, Figure).
Conclusion: Leukocyte telomere length is inversely associated with stent strut coverage after percutaneous coronary intervention with DES. 
Leukocyte telomere length may be a useful biomarker to predict neointimal coverage after DES placement.
